Re: SEROQUEL Law Firms have sold their clients down the river

August 27, 2011

I see what you are saying...yes, if their reputation makes them suspect, then

they become a liability to others who are working against the widespread use of

psychaitric drugs.

And yet, for a person to be told by an individual calling himself a doctor, that

the only reason she is concerned about the damage of SSRIs is that the

Scientologists told her to be, is an outrage. She herself was suffering bad

effects, and she is told she ought not be, her adverse effects are due to the

darn Scientologists, of whom she personally had never heard? Whew!

I know so many people who have been injured one way or another by these drugs,

even in my own household, and as Dr. Breggin stated way back in 1995, the

patient is often the last one to know he or she is being harmed. I guess I am

beating a dead horse here, every body on this list has probably moved on from

these things years ago, to more current issues, but I have been out of the loop

for several years, in part due to the mess SSRIs make of lives. I know there are

people on this list who have lost loved ones permanently because of them. I

guess we are lucky that our lives were simply ruined, with everybody surviving,

if you can call it that.

I know the use is not down all these years later. That is the crime of it all!

Until the pharmaceutical companies are reigned in with all the rest of the

special interests, the situation cannot improve. And now the Republican Party in

the US is gaga over Gov. , who did not hesitate to try to force every

schoolgirl in Texas to submit to Gardasil when it first came on the market.

Cate

> > > > >

> > > > > " Awry, " not " a rye " but I digress. This is exactly why I never

> urge

> > > anyone to sue. The deck is stacked against us in court and attorneys

> are

> > > looking for a quick and easy buck. No justice is to be had.

> > > > >

> > > > > Terry

> > > > > Sent via BlackBerry by AT & T

> > > > >

> > > > > SEROQUEL Law Firms have sold their

> clients

> > > down the river

> > > > >

> > > > > Weitz & Luxenberg p.c. Settlement Letter to Seroquel Victims -

> TIME

> > > TO

> > > > > REJECT this Insult on Top of Injury

> > > > >

> > >

> [data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAeAAAAHgCAIAAADytinCAAAgA\

> \

> > > \

> > > > >

> > >

> ElEQVR4nO2dP08yzdfHt7qDzRV+WFuQWGBh5RuwotBX4NVYmPAK7HwBxNKSxI7qaehotWJtC\

> \

> > > \

> > > > >

> > >

> A2xMBZmY2JCZUJCrMw8xcFxL9hd9s+c+bffT6Z5nvxuL1hmPgxnzpwTCAAAAFYSmH4BAAAAk\

> \

> > > \

> > > > >

> > >

> oGgAQDAUiBoAACwFAgaAAAsBYIGAABLgaABAMBSIGhgKV/R+1f0vpq/fD6END7u7uPj9eo65\

> \

> > > \

> > > > >

> > >

> 3i7uY3/h4vhSP5N+ldMv1cAkoGggRm+l6vv5Yr8uxiOpHCfzy5nJ+ezk/PZ4ens8PSpdSzHJ\

> \

> > > \

> > > > >

> > >

> DiYNNpyPAb7OcfGfxj/m/SvzA5P6R+l10Ae/3wIV/MXep2mnxaoKRA04OV7uaKN8Gr+IkX8f\

> \

> > > \

> > > > >

> > >

> HY5OzwN9442xqTRngQHvyNm1fjY/g/zj+S/+e8/uvGfzA5Pn88uaSe+GI7ovXxF7xA34AaCB\

> \

> > > \

> > > > >

> > >

> oohHZOL325uaUcsN7wZHrR8bEicrE3BE7I2QiVAORA0qMr3ckUBYqnj2eHpRoTBuF6ZfC3f4\

> \

> > > \

> > > > >

> > >

> 1PreHZyThttCo9gfw2qA0GDMtAe+fXqmnT81DqOB4W9NPIOXzfa0tcU5qa49uvVNe2vTX9iw\

> \

> > > \

> > > > >

> > >

> EkgaJCLr+idtsmvV9dk5HAjZOxayIJd2T9Phv7P2eEpba4Rvwb5gaBBKhtS3jAORmFl/3yfS\

> \

> > > \

> > > > >

> > >

> VlTnp/pzxnYCwQNNlnNX9ZSjh/uYYOs2tT0VClyTbI2/ckD64CggRBCfC9XMqZMGcfwsk5Ty\

> \

> > > \

> > > > >

> > >

> 2NGilkjAAIICLq+UIYyefn3JggCykZlTRGkp9bx89nlYjhCtLrmQNC1Q2bFPZ9dhnSWpeICC\

> \

> > > \

> > > > >

> > >

> IaqEb8+E+4dyQAITF1DIOgaEfdyPZPhXBwUAwljpjY9j4A+IGj/+YreyctPrWNElt0dMlRNp\

> \

> > > \

> > > > >

> > >

> kb6Rx2AoL1luVwuhiPycviTlmvcMhgVhzwkiMepTc81wAUE7RsUYn67uV1nLiO47O+gOPVT6\

> \

> > > \

> > > > >

> > >

> /jt5hZBai+BoP2B8pefzy6RiVG3QScKFPrAtXKfgKB94PMhpMt+CDHXedCnT9cUcZboBxC0w\

> \

> > > \

> > > > >

> > >

> 9DtktnJeYgQM8bPkDNhdnKOOy+uA0E7yWr+so4yI4UZI2XQxJgdnr7d3CLu4SgQtGNQNCOks\

> \

> > > \

> > > > >

> > >

> CO8jJFjUBo14h4uAkE7A+XMUfUiqBmj0KBpE+4dUWae6bkM8gJB244MNEPNGNWHLKGH8LQTQ\

> \

> > > \

> > > > >

> > >

> ND2QjcAEWjGUD5kW0XcSLQcCNpGpJqxZcZgHZSWB01bCwRtF9/L1cfd/ezkHMWMMPQMKsY0O\

> \

> > > \

> > > > >

> > >

> zn/uLtH0MM2IGiLWAc0kNGMoX3IXlwfd/em1wH4BYI2T/wYEFe0MQyOtaZxhGgNELRhPh9CW\

> \

> > > \

> > > > >

> > >

> T3D+Pq0bci69TToKnPF8ds1Bj1wM558cPB8dom8aeNA0MagKydwRBjr9hQXMdVpo059z2eXN\

> \

> > > \

> > > > >

> > >

> N5ubt9ubl+vrqkrdp4h//c05J+i7ouyRvamvmv/O4aeA663mAWCNsBX9E5tAOuTpPHbxmlrh\

> \

> > > \

> > > > >

> > >

> HtHpODXq+u3m9uPu/vFcPT5EH4+hKv5y2r+Qn35aFR/+PJPfUXvNOjfWgxH0uak750vuw6DW\

> \

> > > \

> > > > >

> > >

> gS8Xl0jzcMIELRW1kka9TgJ3AgjPLWOZ4ens8NT2ghT9ya18lWFfEmr+Qv1CXu7uSVrzw5P4\

> \

> > > \

> > > > >

> > >

> w0Q6rDdjp8fWvUx1QEIWh+/4WZP1zNFKmTJ09nhKW2N325uaVPswS6MdtyL4SiubLrk6X2tV\

> \

> > > \

> > > > >

> > >

> 3l+aPpDqBEQtA5W8xePw80ycEzxYooOL4aj1fzF+w0X7bIpPPJ6dU1x7d9wtneyloFplMfTA\

> \

> > > \

> > > > >

> > >

> wTNDtUF9Wlv9RuKDQ6oMx61XFrNX5bLpennbRIZFaH99VPrWHYd8+bTD3/uH77d3Jp+3v4DQ\

> \

> > > \

> > > > >

> > >

> TPy+RDOTs792DjLeCtlPkgp2xY+tgd6MlLWs8PT+GM0/oEqmQ+zk3PkeLACQbPwFb2/3dzSP\

> \

> > > \

> > > > >

> > >

> Da+liquQ/q1Tod7r1fXuMJQDrqORGEQOiX2IAxC0/vt5taD0wU7gaDVQ9cCqfyuuyPe4A6tS\

> \

> > > \

> > > > >

> > >

> NVC7X2pjeTa1C5rmkp54PCQAwhaJZTg7PRvWPnTlSIY2BmxQjkh6+5lPxl7Lsqafg0gXVo5E\

> \

> > > \

> > > > >

> > >

> LQyFsORownOMrhMXq5D9oVtfEXv6z6TJ+fro0XXoh90aDw7PMVWWiEQtALWG2fXDuvpx3W4d\

> \

> > > \

> > > > >

> > >

> yT3y6YfJBDipwYAXWWkQJPxqVJoUk0abWylVQFBV+XzIaSNs/G1UWwVBQcUX8ahn538Hioen\

> \

> > > \

> > > > >

> > >

> rqo6dnhKb7yqwNBl+d7uXq7uaVfdsaXRP6VE/50DsUexwm+onfZL9ihmSaj0vj6rwIEXRKHc\

> \

> > > \

> > > > >

> > >

> pzlwqbLBQgxO8o6SB3LpzY+tfJMPORKVwGCLsPH3T2d5BhfAztWyM/pH22Z4WU/oA31uhqiC\

> \

> > > \

> > > > >

> > >

> 5PwqXWMRi3lgKCL8ZtIZ/dhoGw0h9M/X1mfJVIVARc0jZPDEkDQBaCwhuXHNTKRGa2a68C6A\

> \

> > > \

> > > > >

> > >

> bwL0Ta694TtQiEg6Lx83N3TJDM+0ZO9/JPkh2hGDaGiH+uDRItzPWn5INyRHwh6N5bfD4wHm\

> \

> > > \

> > > > >

> > >

> rE9qTmkaXnVxfjkTJiujTbCHfmBoHcgszWMz+zEITsSQc1AQuFpm3uqIbsjJxB0FovhyNpsD\

> \

> > > \

> > > > >

> > >

> XpVUDNIgzQd2lpSkX724V54NhB0Km83t3b+TqQ9EbpagDxQN5/w55TC+OzdcPQkOEDh/wwg6\

> \

> > > \

> > > > >

> > >

> AS+ovd180Cb7EyN76BmUAKpaQuDHpPg4PnsEiHpRCDoTVbzFwuDzrSucAwIqkBHiKF9yUgUk\

> \

> > > \

> > > > >

> > >

> sa2YxsI+h8+H0Lbgs4yrxnROqAEmc5v2zx/ah1j/7EBBP3Lx929VfVoKGhIBXaR1wwUQqXy1\

> \

> > > \

> > > > >

> > >

> uXLrYl40ItBlnQcCFqIeF06mybrU+v47eYWagZM0LS3KmlaHhti2hMQtPhertZHgnbYmebo8\

> \

> > > \

> > > > >

> > >

> 9klQnJAA6v5i21H4jT/4WgBQX9F71aV10D/TWAE2enYkm0KLQSkdtRa0FYVP6L9CyocAVNQ3\

> \

> > > \

> > > > >

> > >

> aXQmost5OiaHxvWV9D2tKqi6ApiGsAG1hEPO07L0TqrpoK2J52OajDi5BpYxcfd/brStOmIR\

> \

> > > \

> > > > >

> > >

> 83T7+oo6MVwZMMGgY5lcC0Q2AldPrTh8JBeQz0PZmon6LWdLdgXUIKz6ecBQBYyXdr4egn3j\

> \

> > > \

> > > > >

> > >

> mq4Xuol6Leb29D0GYjMosNhIHACS+qh076qbpWVaiRoG6rTUfnmGm4EgOtQo2TjKU91q35XF\

> \

> > > \

> > > > >

> > >

> 0GTnc3OrcdgH6kawF0owcP4yWGtHF0LQRu3M/3r9ZlVwGNsyJWuj6P9F/Q6smHuOx+5nMAz6\

> \

> > > \

> > > > >

> > >

> A6B2a10TRztuaDN2hnngcBXbGhqUQdH+yxos3ZGh3ngPRTuMHhy6L2jvRW02bgzwhqgJsiSC\

> \

> > > \

> > > > >

> > >

> QZ/p3rsaD8FbdzOCGuA+iDDHQZXnK+O9lDQi+HI4ERBuXFQT9YtL0xomu6weHm9wDdBG7zJj\

> \

> > > \

> > > > >

> > >

> UsooOYshiNTNch8vQvulaA/H0JTdkbQGQBhuorvpNH2bA36I2iDFUQRdAZAYjAk7V9tUk8Eb\

> \

> > > \

> > > > >

> > >

> ep7m4Jur1fXCDoDIPlerl6vro38nPXst6wPgqa+ggbs/HMkaPoBAGAjVLhD86pcO9qXfobOC\

> \

> > > \

> > > > >

> > >

> /p7uTLSV9Djg2MAqkPV7wxeE5udnHvwu9ZtQX8vV0a+pf0LdQGgkI+7e+NtMah4pOuOdlvQR\

> \

> > > \

> > > > >

> > >

> i6kUJALVUMBSGRd7s5006LQiwssDgvayLc0/XSCnQFIxIa98z+ObrSdrofjqqCNXEhBOh0AG\

> \

> > > \

> > > > >

> > >

> Xzc3RtvWrQtaKeTo50U9Gr+oj/lmezsekgLACZs2zvHV+5T69jRX73uCdpIUp0fBw4AMGFP3\

> \

> > > \

> > > > >

> > >

> DnN0Y4m3rknaP2XlB6DfVxFASANa/fOG452cY/lmKD1p23QRUHT7xsAS3HCznItO5fU4ZKgF\

> \

> > > \

> > > > >

> > >

> 8OR5iOIx2DfuU8UAG1YeCqYJehGexIcuHW5zBlB66+FhL0zABk4tHeOL2q3rpi5IWj9B4MUd\

> \

> > > \

> > > > >

> > >

> zb9vgGwFMtPBbMd7dCBoRuCfr26hp0BsAQX984bjnZlgTsgaIpz6fzwXDztBUAPrttZLnMnb\

> \

> > > \

> > > > >

> > >

> hjaLmjNTVJgZwAy8MPO4U9wxv5gtNWC1hx6xm0UADJYx50dydnY7WgXgtFWC/r16lpbKVEnP\

> \

> > > \

> > > > >

> > >

> i0ATOHN3jk+7D9tslfQOkPPqCAKQAZu5TsXXfs2B6MtFfQ661nL1/Wk0Xa3lgoA3Hi5d94Y1\

> \

> > > \

> > > > >

> > >

> gajbRQ0dbHS83VN/4q1Hw8AZjGY7zwJDjRt0YIDa/tj2ShobVnP6CsIQAam9s50XP92cxvq+\

> \

> > > \

> > > > >

> > >

> m6wNjPaOkHrzKtzsXgKAHowZWfaz1LIkYqjaXgN1tb1t0vQX9H77PBUT+aGtd+ZABjHrJ3jy\

> \

> > > \

> > > > >

> > >

> VTafk8/Bvuzw1Pb8rjsErS+4AYupACQgqm4c3zvLPlerrSVgLdw02aRoKnNoKZ5gKQ6AJIwd\

> \

> > > \

> > > > >

> > >

> Rslox3zav6i7Yd1uHdk1aGULYKm4IaOYJPLDcoAYMVUvnPi3jmOtjakk0bbqkCHLYKm4IaeH\

> \

> > > \

> > > > >

> > >

> bRV35AAWII9cedE6Be2nj2cPYEOKwS9bpWi5dEjbQOAbayKO6ehp+OdVRkd5gWtrSISDgYBS\

> \

> > > \

> > > > >

> > >

> MTCuHMaeg4M7anMY17Qbze3GsL/dubQAGAcG/Kd86MtE9eSfqSGBf35EOqZCm41IgNAD5bHn\

> \

> > > \

> > > > >

> > >

> RPR2Z7UuDQMC1pbcMPmglUAGIEiG/pH9QCCnlKX9DoVPvASmBS0tqf8fHZp8G0CYCEOxZ0T0\

> \

> > > \

> > > > >

> > >

> RaMNru3MybodeIz8yOmOykIPQMQx624cyI1EYgxQWvrlmI8igSAVVh7G6Uoek6wzHZdMSPoz\

> \

> > > \

> > > > >

> > >

> 4dQQ+KzJeewANiDi6eCGejJAZsEB6b2eQYEraceP5WU1f/uALAWU7dRVMWdE3k+u+R2tMErF\

> \

> > > \

> > > > >

> > >

> AYEreFsEAU3ANjAYPV9PjsLXWU6TJ0W6ha0nqJIk+AABTcAkHgTd06EakVwvxcjp4W6Ba2h4\

> \

> > > \

> > > > >

> > >

> jPy6gCI41ncORE9YtF/WqhV0BquABlPiwHAKpyoglQdDVl3Ri4kaxW0htS6x2AfwQ0ACF/jz\

> \

> > > \

> > > > >

> > >

> okshqPHYJ/1zepPudMnaA3dYOnxoV4dAMJ0ZMPIEb2GLaDmSqSaBE2NxVifHYIbAEjqEHfeR\

> \

> > > \

> > > > >

> > >

> kOgg/J3te0CNQlawzHrpNFGcAMAYboKktn0Vtl4he/7SWeSmCZBz07OWb/MkbkBAFGruHMi3\

> \

> > > \

> > > > >

> > >

> HWUJo22tip3OgQtZwzrpLFhZgBglhrGnbdZzV/Y32+jrefeCrug9USFUO4ZgHrGnRPhrtGh7\

> \

> > > \

> > > > >

> > >

> cSLXdDrK0xsk4YmBzI3QM2BneNoKPij5/I3r6DpMXF/leFsENQcL6sgVYQSE1zfGvIK+uPun\

> \

> > > \

> > > > >

> > >

> tvOOBsENQdx5zS4Tws1BFcZBf29XLHWRZo02ihZB2oOIhsZrAvdcSpodnjKuolmFLSG7TPq8\

> \

> > > \

> > > > >

> > >

> YM6Y7bOhuV2Jt5ubp3eRDMKmnv7zP3dBYDNIO6ch/XveE5Hs4qIS9B0n4fvoeBsENQZxJ3zo\

> \

> > > \

> > > > >

> > >

> +EaM5+LuATNmuOC1DpQZ2DnQnDnkrHqiEXQ8jo8y+NotFF2A9QWnAqWQEMpTSYjsQiatXAdu\

> \

> > > \

> > > > >

> > >

> sGC2oK9c2kclZJ6QWv4sjLVAh0Ag6AKUhU+H0LGL7BGm6lOtHpBs9bMnjTa+tuCAWAc7J2rw\

> \

> > > \

> > > > >

> > >

> 9q3kKnZimJBa6gj5cdcASA/iDsrwUU7KRY0a1q4ka66AJilJl1f9cC9iVZ+dU6loLnvdnN8Q\

> \

> > > \

> > > > >

> > >

> QFgM4g7q4U20XzPU/mlFZWCZr2cor+fLgBmQdyZA+5DMrX5dioFzdfXahIcPLWOkbwB6gPiz\

> \

> > > \

> > > > >

> > >

> kx8PoRPrWOmQIfybljKBM2bxYLoM6gTiDuzwreJVp5vp0zQfNF3KiuK7TOoCYg7c7PeRLP93\

> \

> > > \

> > > > >

> > >

> Fe4m1QjaNbGg5NGG1cHQU1A3FkPfLX81bYrVCNo1tLPTFd0ALANxJ21QReemZ6nwiLRCgT9v\

> \

> > > \

> > > > >

> > >

> Vzx3XPH9hnUBMSdNcO3iabSHEry7RQImrX4xiQ4wPYZeA8iG/r5fAjt/92vQNBvN7dc22fUf\

> \

> > > \

> > > > >

> > >

> QY1AHY2AtWJ5ttEK7lVWFXQX9E733mohqa5AJgFcWeDsB6eKblVWFXQfO1k1B6GAmAh6PpqF\

> \

> > > \

> > > > >

> > >

> t70MxVt+aoK+vns0ol0QgBsY21n5nZ5aXaubWRjA9ZLK9UTHCoJmi++gbvdwG8Qd7YEvksrd\

> \

> > > \

> > > > >

> > >

> MOu4s+USoLmm2ST4ADZdcBXEHe2Cr58u3DvqOIpWiVBs74xtIUFXgI728ZiOOJ75hU3muUFz\

> \

> > > \

> > > > >

> > >

> VoUSnlZVQBswFTcuT51NsrBVMi+eqi2vKD5MlQmwYHyxgQAGAdVkKyFrxVUxVzhkoJmvd4do\

> \

> > > \

> > > > >

> > >

> nMK8I6Pu/tJcICcDTvha1dY8dp3SUFT9WemHwXIrgOegbiz/bC2Kyz9BVlS0KzxDRwPAp9AF\

> \

> > > \

> > > > >

> > >

> SQnWAxHTE6rEuUoKWim/A3cHgSegXxnV+C7VVgll6OMoL+id6ZZhc6wwCdgZ7dg7Sdbbt9ZR\

> \

> > > \

> > > > >

> > >

> tB89TdCpD8DX0Dc2TlYE6LLma2MoJnqb6C4KPAG1NlwEb4CpJNGu1xsoLCgv5crvvobiG8AD\

> \

> > > \

> > > > >

> > >

> 8CpoLvw5XI8tY5L7D4LC3oxHD21jplmGKojAddB3Nlp6II002dUIspRWND0DcMx/2Yn50VfD\

> \

> > > \

> > > > >

> > >

> ABWgbizB8xOzu2JEBQWNFeMBte7geMg7uwHTNe+6WMq+mKKCZqvQNIkOMAMA+6COhvesJq/M\

> \

> > > \

> > > > >

> > >

> J0TPrWOi35SxQS9rifAEd9A+TrgLIg7+8T3csVX3K7olcJigmYqkKSqAy4A+jFbBQlxZw7eb\

> \

> > > \

> > > > >

> > >

> m6ZRFc0DF1A0F/RO18AGvkbwEXQ9dVLPh9CjlBBiU+tgKA/H0KO33GovwEcxZSdEXfmhrEuR\

> \

> > > \

> > > > >

> > >

> 6NdaDNaQNBMFexQfwO4COLOfsNUl6NoZbsCgmZ6xSUC5wCYBfnO3kNHCxyCLrQfzSvo9Z6fJ\

> \

> > > \

> > > > >

> > >

> 76B7QBwCNi5DqzmLxxRjkmjXSiim1fQXLmBpZK3ATAFur7WB76q9/nD0HkFzbThR4Ek4BCIO\

> \

> > > \

> > > > >

> > >

> 9cKpsJJhYK6eQX9enXNNC9RABo4Abq+1g0qDMfhvfy70ryCnh2eckw+XCAEToC4cw3hu1I4O\

> \

> > > \

> > > > >

> > >

> zzN+RpyCXo1f2H6JindqgsAbaAKUm1hak4S5u7znUvQTJ1gJo02bngDy0EVpDrzdnNrNrSbS\

> \

> > > \

> > > > >

> > >

> 9BMAWjc8AaWg1PBmkN3vtV/vrk7YOUSNFMJjnI9YADQA+LOgKnDX/704t2CXkfKlSdsBwfPZ\

> \

> > > \

> > > > >

> > >

> 5cQNLAT9BUEBEc2NF3Qy2O/3YJeF+lXPVNRYhRYCyIbQMJRepSK9+cJ8O4WNNNkfQz2EYAGF\

> \

> > > \

> > > > >

> > >

> oJ8ZxDn8yFkqUHUaOe5rrJb0Bw1ksp1fwFmiaIoiqLpdDpOYjqd0v/A9MusRK3izhkfqB+fp\

> \

> > > \

> > > > >

> > >

> hKYkoxzhhB2C5qjiwpNRwSgbWa5XI7H436///fiotvtdn5optOJ8ffiotfrDQaD6XS6XC5Nv\

> \

> > > \

> > > > >

> > >

> 5tc+G3n5XI5nU7zf6DtP632n1an0+l2u859lAr5Xq44siQeg/08t0B2CJqpi4rCGtDL5XKgj\

> \

> > > \

> > > > >

> > >

> vF4vDEFp9Opwr8/nU4z3st4PFb4b5XY/sg13O12m81moIhms9ntdvv9ftEVrvbDzebt5papI\

> \

> > > \

> > > > >

> > >

> fLO8X+Ndr/fT/z0K+5hlX+gzWbz78VFlRem8zNNY3uZZ8MSRcj3rbxD0OvtPYOgVdWAnk6n1\

> \

> > > \

> > > > >

> > >

> aedpP2ntTHz/l5cKPz7/X4/7Y0sl8tOp6Pw3xqPx/kfYxRFg8Gg2+0qfAGJdLvdQe7lHUUR9\

> \

> > > \

> > > > >

> > >

> +sh/v73PyNqJju3/7TSXlihDzGO9DLTE2s2m71er8TLU7tgS7/4Ql8wHL1KclZa3iHoxXDEN\

> \

> > > \

> > > > >

> > >

> HFV1UiaTqcK93qdTmfjk+v1eqr+eLBL0GqXU/7F0+/31X437KTT6fT7/Z27GD2C/vvf/4yoe\

> \

> > > \

> > > > >

> > >

> aedg1KCjqKo1+tl/1mFdLvdolsBhQu2HNvLPJvFcMSUKLFTgzsEbfCrIycQdBp5ls14PNas5\

> \

> > > \

> > > > >

> > >

> jidTif7RWoQtM12DooLut/va1OzhHbT+X8VOSdopuL9eQIJOwTNkgOo9IQQgk5j59oeDAYK/\

> \

> > > \

> > > > >

> > >

> 7nSZDwTbkFbbuegiKCjKNIQocpg59etfJ3OCZrvnHBnIkeWoL+XK6ZbNAqL2EHQaWSvln6/r\

> \

> > > \

> > > > >

> > >

> /Dfqkiv10t8kayCtt/OQW5Bj8dj49YjBoNB9kt1UdCCLZlt523qLEEz9R6fBAcK7xBC0Glkr\

> \

> > > \

> > > > >

> > >

> G2r7EwkPhk+QTth5yCfoC35JSTJdrSjgn67uWW58L0rkSNL0Kv5i/1dVCDoNNLW9ng8VvivK\

> \

> > > \

> > > > >

> > >

> GT7BTMJ2hU7Jz4TJz7NjJftqKCZSi6HuwpD7xA0xx3HnJfQcwJBp5G4SKIoMngqmE2n09nI6\

> \

> > > \

> > > > >

> > >

> +AQtEN2DnYJWu3kV0hGHpujguYrSZQtwyxBc+TYFe06vhMIOo3EtW1hcCPOxq9j5YJ2y87BL\

> \

> > > \

> > > > >

> > >

> kGbPRXMptvtJkZXHRX0Ot7LUHc0O5yQJWi+sEuhR5MNBJ1GYsTA+NrIptPpbLxghX/cOTsHr\

> \

> > > \

> > > > >

> > >

> h0kbJAYjLZhEpYQtKCy+AyCzs60yxI0R9fxSaOttg8hBJ3G9tq2f0kH/75shYJ20c5BuqBt0\

> \

> > > \

> > > > >

> > >

> NxOtmNWlrzycoLm6E84CQ6yi15kCZrlBanuQwhBp7G9ttVGn2V1JLXrLf6IVAnaUTsH6YJ24\

> \

> > > \

> > > > >

> > >

> rs2sPVnXDlBc/Qn3LlhTRU0X8txVVU4CAg6jY21oXBhNJvNwWAgN0dRFPX7fVV/vNvtxl9z9\

> \

> > > \

> > > > >

> > >

> T/orp0DXSe9VK+u1+upLZIV/PtpKp+HpSknaCp2qHySZLdWyRI006xVW6cfgk5jY20rzJZNj\

> \

> > > \

> > > > >

> > >

> C2q2tN1Oh05X6sL2mk7BymCVptat/FpKr/9v7Gg3BX050PIlHZcRtCr+QvTxFVbpx+CTmNjb\

> \

> > > \

> > > > >

> > >

> at6I4mBRULJwo4XFKwoaNftHKQIWmGFxb8XF9t/n/ULwF1Bf0Xv+pWYKujPh5Dp1ait0w9Bp\

> \

> > > \

> > > > >

> > >

> 7GxtlX98bRr2aqelSpBe2DnIEnQy+VS4YRPi3Er3ERvRDlsEHTRcqOEkaBCqqCpq7HykbOXb\

> \

> > > \

> > > > >

> > >

> X4g6DSYBJ3xFpREOTYEndHAZRv5R0zZeRIcKLRzkCRQhdvbDE8pnIrbqZNqBV1ohhDldtDrk\

> \

> > > \

> > > > >

> > >

> kkMUY6MVOgsQXPklOwsDlIUCDqNjbWtak+U8RaUhLnjgqa2WzmZTqf0Hg3aeXZ46lCuZLPZT\

> \

> > > \

> > > > >

> > >

> PsoFb6Lja8BtYJu/2kNBoO0PpkZU6WEhdbF4/TmTaQK+vXqWn/SXwkg6DTia1thu5aMt6Ckp\

> \

> > > \

> > > > >

> > >

> tp2U5v8dDodk3Y+OV/NX7gFrTAArU3QG7ntaheszjaJHFdDwr2jjMxj3YJWmwQtIOh0aijo/\

> \

> > > \

> > > > >

> > >

> 2u0OarH5LQzFTBwKJldj6CDf88JlQtaZ+txlsvVjXbGtjVV0EyVoNUmQQsIOp26CZrp1CSnn\

> \

> > > \

> > > > >

> > >

> ekgXsNtI4UBbgi6KB9395rr46cKmqmDgMJCowQEnUatBE1HJkxpqjntzP0hCtV2g6CLshiOm\

> \

> > > \

> > > > >

> > >

> DpMpf2LyYJeXyNkELTaJGgBQafDJOiMNDtTgjZr53hpRm5Bq53tEHRROCowZ7cATBY0Uy+Vn\

> \

> > > \

> > > > >

> > >

> cVPSwBBp8Ek6IwloSQDrGiOqj125v4QBXbQW2gW9OdDyFLgM70Csz5BT4KDp9YxdtBpb8QVQ\

> \

> > > \

> > > > >

> > >

> Qfp74JuCZfISy2do0pxZ/12fgz245ENPR+igKC30L+DVl62v4yg1+0D1Aq60Yag/RB0s9mcT\

> \

> > > \

> > > > >

> > >

> qeJbyFSQc6P3pK4s7YPUUDQW/gg6EZ7dniaJsZMQSv/otjVIbEEEHQaTDcJiU6nk+hobVhoZ\

> \

> > > \

> > > > >

> > >

> wFBp+CNoL+id47siYwugFoFrfwaoYCg02EVdLB1AUEnVsWd40DQiXgj6PVlQuOCXgxHEDThj\

> \

> > > \

> > > > >

> > >

> aDVvhFJv9/XeZVL2JHvnAYEnQgErVjQHDsUCDrwpR70Bt1uV9tW2tTeOe1UcAMIOhHPBM1xW\

> \

> > > \

> > > > >

> > >

> zXtBp8+QT8G+8oLcQgIOp3tta3wj2/z9+KCOyptZ9w5DgSdiDeCFkK83dyqT4VutMsIWu2Lg\

> \

> > > \

> > > > >

> > >

> KAD0z0JlYehN2g2m71ej2nBWBt3jgNBJ+KToF+vriHoAkDQaWwLmi/KEYdD06bynfPvnfV8i\

> \

> > > \

> > > > >

> > >

> BD0BpRNVCiJs+KRCYegw6IhDo6iTRB0YFrQaptxZNPpdAaDgRJNWx531vkhahO02raEfIIuw\

> \

> > > \

> > > > >

> > >

> XYf20JYEeLg+JZ4DPaV1xoVEHQ6iQd3Csu956HT6fT7/Sonw6bsHO4dFbWzhg9Rm6AHg0FPH\

> \

> > > \

> > > > >

> > >

> fHDCdcF/XF3z+HGtM2rVkErrzUqIOh0EgWt9kphTrrdbmIj8J0YtPP/NdolUlO8ETQfEDQEX\

> \

> > > \

> > > > >

> > >

> R7vBS1U92zOT7fbLZTmYSruHP50fYWgOYCgIejy1EHQQnugI07Oiy1m985UFB+C5gCChqDLU\

> \

> > > \

> > > > >

> > >

> xNBK39fhdi5lbbBzjsfoJEPEYKuDgQNQadij6CVv7VCNJvNtEdhiZ3zPED9HyIEXR0IGoJOx\

> \

> > > \

> > > > >

> > >

> SpBK393Rfl7cbER7jAed46/PAiaAwgagi5P3QQtjMajgyDodrvygduzdyYgaA4gaAi6PDUUt\

> \

> > > \

> > > > >

> > >

> BBiMBjoz72T0GWwxXBklZ0DCJoHCBqCLk89BS2EiKLo78WFwn+9EH//+5/yDj4V7RxA0DxA0\

> \

> > > \

> > > > >

> > >

> BB0eWoraGIwGKTZio+///1vEhxYtXcmIGgOIGgIujw1F7QQIoqiXq+nbQn9/e9/+r2cx87lH\

> \

> > > \

> > > > >

> > >

> iAEvRMIGoIuDwQtnyp3bdLAbjuXe4AQ9E4gaDWC5qhmB0G7ImhiPB7zadpyO5d7gBD0TlwXN\

> \

> > > \

> > > > >

> > >

> Ec1u8KCZqoHjWp2bgmaXhWHpu23c7kH6I2goyiaqiOe7e66oFkK9gcHaW5Ewf5/gKDTXpvCV\

> \

> > > \

> > > > >

> > >

> Dwn7FzuAXoj6G6321RH/F0oF3T7T6tThF6vV/RjjWNFwX4IWgJBS76Xq36/X1HTrti53AP0S\

> \

> > > \

> > > > >

> > >

> dCq/pUALa92jZItr5Q3jUWIw2lBE5TmUe4lOWTncg8Qgk4EgmYQtOpDwklw8Hx2WaW5RiIQd\

> \

> > > \

> > > > >

> > >

> BpMgibG43HRrbRbdi73ACHoRLwR9Pdy9Xx2qd6NRQX9+RA+tY7V7qAh6MAjQYuClw+ds3O5B\

> \

> > > \

> > > > >

> > >

> whBJwJB7xyL4SjxX4Sgd3ze3gh6PB73VbDxZ/M8HxftvP0A8wBBJwJBZ4+n1vHnQ5j4L2oV9\

> \

> > > \

> > > > >

> > >

> Ozk/Ct6V/vIIOg0Nta2qhyM7Syl7EfkqJ0DCFod3gj6K3qfHZ6aF/Rq/sIh6KfWcdE2yTuBo\

> \

> > > \

> > > > >

> > >

> NPYWNuq/vjfi4vtF58W63DXzgEErQ5vBM0ixka7sKA5vigg6MBfQUdRtL1Dd9rOAQStDgg6W\

> \

> > > \

> > > > >

> > >

> 4yzw9O00II+QdNLgaDT3ojTghZbhf9dt3MAQavDG0F/PoQc1wgLC/p7uZqdnHOU44Cg096I6\

> \

> > > \

> > > > >

> > >

> 4KOokhq0QM7BxC0OrwR9Gr+wiLok/O07IlkQQshmASdlk1SGgg6Dc2CFhPrUikAABr4SURBV\

> \

> > > \

> > > > >

> > >

> D+RaD/sHEDQ6vBG0IvhiEnQaf+iVkFPggPlBe0g6DT0C7rX65myMyVxqm3cBUGrwhtBc9Qap\

> \

> > > \

> > > > >

> > >

> amb9i+mCvr16lp5OY6Mok2lgaDT0C9opjoyO8djsE8ZnBB0ISDoorzd3HJcI8woUqRb0MrrJ\

> \

> > > \

> > > > >

> > >

> UHQaWgW9MfdvX41hz+/EOlsA4IuBARdFI5C+eHeURlBcxS0mzTayi8Tcgt6IzmhIr4KmqO6V\

> \

> > > \

> > > > >

> > >

> n47yxNw7wWtdrZD0IXgu+edEfhNFfRiOOJYURnnleWYTqeqPuzEz3swGCj8+14K2hI7ixoI+\

> \

> > > \

> > > > >

> > >

> nu5UngKCkEXYp3bxjDPywj68yFkWldqBT0ej1V92Imft6OCbv9pTafT+N9nErQpO1PceSNr0\

> \

> > > \

> > > > >

> > >

> 3tBq32P2gTNV7Bfs6CZJnPaNUKRIejV/IXp1agtx5G/oFq5z1vtF0DGCdtyuVS49rbfCIegz\

> \

> > > \

> > > > >

> > >

> e6dt3Pq6yBohX9fj6CbzWZ8KioXdLyfFit8Ssy4HZIqaCGE/q+LoqgNyQVJXouiSOHfz+iHp\

> \

> > > \

> > > > >

> > >

> nbibv9DygVtT2RDUgdBKzy11iPoTqfDN8+bzWa/3x+UoqjZPx9CptmeEVRIFfT3cjU7PNUcc\

> \

> > > \

> > > > >

> > >

> CnEdDpVuyCDlF9MCv+V9p9W2rRQG0zf3qqrWtj0ly20s9pPKrBV0Apjbht72zgK38XGXsF40\

> \

> > > \

> > > > >

> > >

> 1jJRgxwJxx5E+He0ezwtIyghRDPZ5cciRxFU6Gn0+l4PJ5Op1EUUbPh8Xjc6/U4PuZEQfMdm\

> \

> > > \

> > > > >

> > >

> MThzudTKOiPu/un1jHHcXb2SIw7x6mDoNV+kSe+x+VyqXBxbUxFdwX9dnPLIeiMWyoiW9AcS\

> \

> > > \

> > > > >

> > >

> X+UaVfouag1VzaJglabadfpdLZnhtqjyGazuf1PqHoXBu8KZttZ1EPQas8qEmNuamfjxlR0V\

> \

> > > \

> > > > >

> > >

> 9AsG9ZdV0OyBM3UmTDj4nkiOgXd7Xa3QxBq9yxBEDSbzV6vNxgMqMuJ2nPOYCvqRyg57bTZz\

> \

> > > \

> > > > >

> > >

> qIegla+IjZ2uOPxWO0h3sbvd3cFzVTgMzuikCXoxXDE8TM2o7ZeIjoFnZhl8b1cqV113PR6v\

> \

> > > \

> > > > >

> > >

> e13Uf13q1k755kzNRG02syiIAi6MdT+5e2AnqOCXldgVr2D3lk/LkvQHMVPw8z+LonoFHSi2\

> \

> > > \

> > > > >

> > >

> oTqH33cpJ38VPGX5Xvn6m9wG2sFrTbKwUdiwNBRQXN0AQxzVGDOEvRq/sJ0TF+o6KhOQaed4\

> \

> > > \

> > > > >

> > >

> CV2DLGTtO8YUSEMbcrOO08FN6iJoIUjO4bEa1mOCprpZnWYmQQtsgX9Fb0zFR0tlMihTdDtP\

> \

> > > \

> > > > >

> > >

> 62MW0lOLImMxClRNpjuxN6ZqI+g7d9EJx7nCGcFzVLHLkfsLkvQTMVBHoP9Qokc2gSdsfcUD\

> \

> > > \

> > > > >

> > >

> GuPg4yr5OUepv1x5zj1EbRgiESrJU1/jgr6+eySqRJ0dumLLEELId5ubjW3eNlGj6Cz956E8\

> \

> > > \

> > > > >

> > >

> ouLaul2uzufaqFNtEN7Z6JWghZ6o3+FSAsVCjcFzdcCcGcsYYegmToIzA5P8y8/PbNw596Ts\

> \

> > > \

> > > > >

> > >

> Hbbkr9qTM7n6UrcOU7dBG3nr7rsX6IuCno1f+HIsXsM9ndeq94haI4eXDTynxNqEHRGDaNtL\

> \

> > > \

> > > > >

> > >

> AxGN5vN/DbJs6qd2zsTdRO0sC8YnW1n4aagF8MRR2GDSXCwU4M7BG3wq0PCLei/FxdFK6Ba5\

> \

> > > \

> > > > >

> > >

> ejEq4nZRFGU4RG34s5xaihosevT1Emen6EuCpopkPDUOt65F9khaKZEjsdgP3/vK1ZB93q9c\

> \

> > > \

> > > > >

> > >

> vWpOUo1leDvxUW5cotpq9pdO4u6Cpr+XbPx6E6nk/OluihojmabOSf8DkELtuPL/OeETDOv2\

> \

> > > \

> > > > >

> > >

> +2WWIFxaFWYmm3tP62Mo5ic9Pv9+Ot3Me4cp7aCJsbjsf5NA9UtyF813zlB850Q5klm2y1ol\

> \

> > > \

> > > > >

> > >

> kSORjvP9p5QK+j2n9bfi4vqapNMp9Nut6tzznU6nX6/r6qRhHz9jsad49Rc0ES/39ej6Waz2\

> \

> > > \

> > > > >

> > >

> e12S4TX3BL0av7CdIcwTxRht6CZKv8+Bvs5L3xXrCXUbDY7nU6326X6REXnU06m06mGhdHtd\

> \

> > > \

> > > > >

> > >

> hWqOQ5Tu+KcdlbVZEdhv77AWUHTyxgMBsqLcEnaf1q9Xq/cUlJeeqw0OV8/U8WLSXCQ5xxut\

> \

> > > \

> > > > >

> > >

> 6D5LqHnvE9INaBLQ1Wk9fTFiaKICtQp3FPTPoW+WpjeBdV3NmVnJXtnoso82aZ0cN/4a4g/E\

> \

> > > \

> > > > >

> > >

> DK1kq1Dp9Pp9Xrj8bjKFmG5XCp8PlXI+Ww5Qghh7pJEuwW9bq3CcM1x5y0ap6GJOBgMer0er\

> \

> > > \

> > > > >

> > >

> ZBOp9PMpP2nRf+zvxcX1Mgn/zQqzcfdfbh3ZEnXV8DEcrmMomgwGFB52263u3NC0v9A/vTUt\

> \

> > > \

> > > > >

> > >

> suxCqbb1HQXJI/9dgtaCMERI6fvEI8FnUiUif4FYFvXV6CZjNlo+qVZwfdyxRE/yF8WP5egX\

> \

> > > \

> > > > >

> > >

> 6+uOdbwJDhQ2EAWFIUaMugPPcPOwBU+H0KOBbKzkYokl6CZSu2V6E8IVGFn11cArIKpD2GY+\

> \

> > > \

> > > > >

> > >

> yp1LkFTogmHoIv2JwRKQNwZgDxw9CGkkXMV5BK0oH5c2luOAw5M7Z1hZ+AW6/wIHu/lfA15B\

> \

> > > \

> > > > >

> > >

> c2XJ1uouwqoCOLOAOSEL7Sbv9BFXkFzdPgOiwTLQXUQdwYgP0y70pxXVIi8guY7zcyZbgIqg\

> \

> > > \

> > > > >

> > >

> rgzAIVgSi+eBAf5l0NeQa+7jvMkbGP1coO4MwCFYKq0PGm0Z4en+X9N5hW04NzwIwzNCm6jA\

> \

> > > \

> > > > >

> > >

> FCU9WkNwxWVQkHdAoLmqFodFqwNDYqCuDMAJeCoAR0W7FUiCgn68yFk6vtSaM8P8kNxZ/0De\

> \

> > > \

> > > > >

> > >

> 2fgNEwR3XDvaNJoF7o+XUDQjC8ad74ZQNwZgHJQTgRTCY5Cm9ECghac237c+VYL4s4AlIapx\

> \

> > > \

> > > > >

> > >

> GjOLipxigmaKxu60caVQoUg7gxAafguEBbKgCaKCXrd/cV0biDIAHtnAKrAdeej0c5ZpD9OM\

> \

> > > \

> > > > >

> > >

> UELzuRtRDmqg9soAFTk7eaW71Je0ThBYUHzFeXAlcKKYO8MQHVmJ+dMy6REPnFhQTMVEKGBX\

> \

> > > \

> > > > >

> > >

> I7SIO4MQHWoBSvTYilxI6+woJl6wISo318B2BkAJfBFCMp1+CssaL73UC5GAxB3BkAJ38sV1\

> \

> > > \

> > > > >

> > >

> xlb2eYkZQS9GI6Y3sOk0UZdjkIg7gyAKvjit6UrDpUR9Ff0zvQ2UJejELAzAAphuohHo1wks\

> \

> > > \

> > > > >

> > >

> IygBbXqYopyoC5HPhB3BkAhrKUsns8uywVvSwqaqbJduHf0GOwjyrETVEECQC2L4YjPaUUvE\

> \

> > > \

> > > > >

> > >

> EpKCno1f+FTAFp9Z4MqSAAohysq0GhPGu3Sq6akoL+Xq+ezS754DSyQBuLOAChnNX9hWlNUI\

> \

> > > \

> > > > >

> > >

> Kl0clpJQQvOKAeufaeBuDMAHDBd7w6rxTdEFUHTlRsmWaC43Tam8p2xdwbew1e+rkSBpDjlB\

> \

> > > \

> > > > >

> > >

> S3YojY0cFQYB3FnAJhgTX+ueKJWSdBkDTvfmE8g7gwAH6wbzSrxDVFR0F/RO19djoo/DbwBc\

> \

> > > \

> > > > >

> > >

> WcA+FjXuOdZX0+t44orqJKgBX35sJ1+4lYh4s4AsMJ3e7B0/Y04VQXNVJcjxK1CxJ0BYIbv9\

> \

> > > \

> > > > >

> > >

> mBYof5GnKqC5uvfFVbOUHEaxJ0B4IYvVzhUEd8Q1QUt2DrghjUuQIq4MwDc8BUXDfeOHoN9J\

> \

> > > \

> > > > >

> > >

> Zc5FAiaeizypXPU7ajQbNwZdgY1gak57Ho1NdpKxKVA0KzXvuuWb4fIBgB64Muuq3i9O44CQ\

> \

> > > \

> > > > >

> > >

> QvmUE5Ym16FsDMAevh8CPkWmsLDMzWC5j4MrcMmGnFnALTBt31Wm36mRtCCs9liHS6twM4Aa\

> \

> > > \

> > > > >

> > >

> IO1jtAkOFB4gUOZoD8fQj6P+H1pBbdRANAJ326ShsLdpDJBCyFmJ+d8X0q+bqIRdwZAJ+vtM\

> \

> > > \

> > > > >

> > >

> 9vP/dnJucJXq1LQfLcKQ0830bAzAJph7Qw7abTVluFUKWjWW4U0fHIK4s4AaIY6p/AtOuWF7\

> \

> > > \

> > > > >

> > >

> FUKWnDeKgxVR9/NYirujDoboM6wRp9V3R6Mo1jQ1EwWm+hsUAUJAP3wtbqW0lO+uBQLWvCHe\

> \

> > > \

> > > > >

> > >

> FzfRH/c3U+CA9ZD5ORHh7gzqDevV9esl1M41KRe0JRvRztE5Y+D/qC76RyIOwNgBNY8YBocX\

> \

> > > \

> > > > >

> > >

> lIvaCEEX2mO8OeeO8fL5gb5zgCYwlEpsQiarwlj+LM3d24TjYw6AExBRuJbfcqz6yQsgmYtt\

> \

> > > \

> > > > >

> > >

> Br+HHY5VCcadgbAFKQj1uwyPh2xCFrQpRVOHz0G+0xfWcpB3BkAgyyGI9Zam+HeEZ+LuATNf\

> \

> > > \

> > > > >

> > >

> Wll0mgrzwnnAHFnAAyi4fYcq4i4BC34i0RPggPlaeFqgZ0BMMvbzS1rSuskOGDtm8oo6PV3F\

> \

> > > \

> > > > >

> > >

> +fTeWodW6shxJ0BMMtq/sJXVjTU8jueUdBCyybazpQ7xJ0BMA5fVX4aCjunpMEraO50DpKgb\

> \

> > > \

> > > > >

> > >

> aeFsDMAxqHimozbZ87kDQmvoIW82ez4Y8rPOu6s/SY36mwAIOHeGob80WeCXdCs7QqlmzQ8q\

> \

> > > \

> > > > >

> > >

> Twg7gyADbCW1Qx/Gg9q2BeyC1rw50TTMK4ns1WQENkAgGCtWieHnk2hDkELzm5YUlJmTwsRd\

> \

> > > \

> > > > >

> > >

> wbAErjPBsO9I7V9rTLQJGjWblhymAp0oPo+AJZAWyXWdTcJDrQlJmgS9PdyxVpNKvyJCunfS\

> \

> > > \

> > > > >

> > >

> yLuDIAlaDjxoh/r2rISNAlaCPH5EHKLTH9jWUQ2ALAH6hbCejNFcylNfYIWzM1WpLm0/fqAn\

> \

> > > \

> > > > >

> > >

> QGwByqK5NkWUKug1zcvmX+A6Al0IN8ZAHv4it41uOWpday5Er1WQQvmrrryOXJ/yyHuDIBV+\

> \

> > > \

> > > > >

> > >

> CGWbXQLeh3Fd/mYFV1fAbAKPUliRnIQdAta/AiO+2kyFbpD3BkAq+AuWScXoJEsXgOCppQ7b\

> \

> > > \

> > > > >

> > >

> kdztHE0FXfG3hmANDTIxGDBHwOCFpRyx1lBSTpaYUV/U3tnnAoCkAZ3zY3QdJdqM4IWWlLua\

> \

> > > \

> > > > >

> > >

> Ch5sjgVBMA2Ph9CDWtQf2pdHGOC1nDnJ1SUdYe4MwC24ZBAqmBM0ELXaWHFYDT6CgJgIRpCz\

> \

> > > \

> > > > >

> > >

> 6G5s0GJSUELqnJn8VNGFSQALIS7DYj0hraqdWkYFrSeKFK5K0CIOwNgIZ8PIfelQTlMnQ1KD\

> \

> > > \

> > > > >

> > >

> AtaaDmHDWlPWiSWhLgzABZCoWc9xlCYA1Ya84L+it61BTpy1gmEnQGwE22hZ0tWonlBC5kWr\

> \

> > > \

> > > > >

> > >

> eW57/xWRNwZADt5u7nVYYlGW2dRzGysELTQUutEPv2MR4+4MwB2Qq1NNaxNI0WR0rBF0HqyG\

> \

> > > \

> > > > >

> > >

> sOfA8NEFaLrKwB2oqFS8XoxNtpmE583sEXQQlfz7zAl+RxxZwDsZDV/0bN7C3f9wtaPRYIWO\

> \

> > > \

> > > > >

> > >

> gMd/x4YIu4MgJ3oqa0mtWBPcIOwS9Dacmjkh/G9XKEKEgDWom3TVjQTVw92CVpo6S0bH89nl\

> \

> > > \

> > > > >

> > >

> 9qS3uMDp4IA7ERP2kZoumRdBtYJWmj8zgz3jri7TGbY2bbvagCsQuehvYXBDcJGQX8vV3qur\

> \

> > > \

> > > > >

> > >

> hgZiGwAsBMqAqHNzqbq8e/ERkELed1e+94WdgbAOHq6WMmhv1d3fiwVtNBVjFTnQNwZgJ3oT\

> \

> > > \

> > > > >

> > >

> KoLLSgomo29ghYau65oszPizgBkQJV5tK16s91S8mC1oLXVUdIwD7B3BiAbSnnWZmcn9kxWC\

> \

> > > \

> > > > >

> > >

> 1roPSuAnQEwhbSzzpMna0PPEtsFLRwPRiPuDMBOdF4XlAvT5tCzxAFBC72Z0crtbPlvKACMo\

> \

> > > \

> > > > >

> > >

> /m0ydqs523cELSLwWjsnQHIA9lZW2TDrW2TG4IWehuRVR+IOwOQB/pxrNPONmc9b+OMoAXVI\

> \

> > > \

> > > > >

> > >

> 9X4WVaZBLAzADvRHLq0qlVKTlwStNBYPKWinV35AQWAKfQfLOXpeGcbjgla6OoaCTsDwMT3c\

> \

> > > \

> > > > >

> > >

> qU5shH+lIA3/dYL456grT0wRNwZgJ0YyXd2d+fknqCFxgZlRWcA7AxABvrznWnnlNaG1H6cF\

> \

> > > \

> > > > >

> > >

> LTQXtff1+9nALTxFb3rvMkt16adlfhz4qqghbk2r7AzAEVZzV+oCpLmBTtptJ24MZiGw4IWF\

> \

> > > \

> > > > >

> > >

> iR1ILIBwE7IzkYayzmXtrGB24LWXP5qezyfXcLOAGRg6ooZpW3Y2SclP24LWvz0xzLiaA++n\

> \

> > > \

> > > > >

> > >

> wFg5ePuPtw70h+HpJQq1+0sPBC0MJ14B0cDkAhFII3snb05FvJB0EKIz4dQZ5uc36nQaFNlL\

> \

> > > \

> > > > >

> > >

> A++qwFQhZGrKL92Pjx1N21jA08ELYxWU6Jolx/f2ABUhNLpTK1Et2oh7cQfQQujydGefW8DU\

> \

> > > \

> > > > >

> > >

> A5Tv2VD91OeE/FK0EKIxXAUmjiUCH8uLLlVKwsAhSyGI4O/YieNtn+rzzdBix9HGxl0JIJjQ\

> \

> > > \

> > > > >

> > >

> 1BD3m5ujf1+bbRdv5CShoeCFvL42NAlQ4SkQa2QQWeDK87XXZGfghamLxkiJA1qgsGgs/d2F\

> \

> > > \

> > > > >

> > >

> h4LWpjeR9PdGS9/dgFA0D0Ug1d5/baz8FvQwlyqvJw9lCWNcAfwjN+whqnF1Wh7b2fhvaCF6\

> \

> > > \

> > > > >

> > >

> X10iHAH8A4Z1jC7rLy3s6iDoIXpeDRNphCXwoEXvN3cyikNO3NTC0ELCxwd7h09BvuofgfcZ\

> \

> > > \

> > > > >

> > >

> TV/0d+tqs52FvURtDAdj5aOfmod4+QQOMfH3b3xPnM1iTvHqZGghdFc+vj3P04OgUN8Re/ry\

> \

> > > \

> > > > >

> > >

> kemwxph/eKE9RK0kHfBTYc76OTQv5upwDMWw5HZNOe4nWu4XmonaCHEYjgyvo+mOfcY7L9eX\

> \

> > > \

> > > > >

> > >

> SMqDSxkNX95vbp+DPZtsLOXdTbyUEdBi1htUsPhjkb7MdifHZ4iKg2s4uPufnZ4avw8MPSxg\

> \

> > > \

> > > > >

> > >

> mghaipoYcEV1X82CMEBEjyADVCqBh3H2WDnmt8hqK+gBTnaUD/DxLkY7h293dzi8BAY4St6X\

> \

> > > \

> > > > >

> > >

> 7cQtGDXEv70FayznUXNBS1++hla4mg5KesZbgMGWQxHtBCM75pp+NRXsAp1F7QQ4nu5Mlssc\

> \

> > > \

> > > > >

> > >

> XtqIuIBtLGOaZjOottYAs9nl+jzKSBo4nu5siFFemOOPrWO325uMU0BEzTtbTgtj097uoqCa\

> \

> > > \

> > > > >

> > >

> U9A0L983N3T2YjxaRqfr5QujfkKFPK9XMkEZ3v2JajQuw0E/Q8GW4NnOJricQhMAyX8hpstm\

> \

> > > \

> > > > >

> > >

> +d1TqdLA4LeZDV/mZ2cWzV3w70jOr15PrvEDAal+XwIn88uQ6Ml9tPsPDs5x6HLNhB0AsaLk\

> \

> > > \

> > > > >

> > >

> SdP4kab1hUuH4Ki0LVA+U1vfDLHZzV6eGYAQadiQ/W75DkdHEDTICdSzfbEmuMzuW7V6YoCQ\

> \

> > > \

> > > > >

> > >

> WexGI5sC0lvaxpBD5DI50P4enVt27l3fAI/tY5xspINBL0Dum1o6RRvtKnANDQN4pCan1rHt\

> \

> > > \

> > > > >

> > >

> gU04nbGLcE8QNC7saQebsZcp80IjhABHQOu1WzldKUZi3roOYGg82JVmYI0TctMD+RN14rv5\

> \

> > > \

> > > > >

> > >

> YrUTIFmO3fNcvkg0zk/EHQBrCqulG3q2cn5x909NineQxWOLMxr3h4oflQCCLoYv+EOWzcpU\

> \

> > > \

> > > > >

> > >

> tNUaRrhaV+hQPO6arPdag4R1igLBF0GGxpo5lwVMjyN++LesBiO7A80xychGiWXBoIuiczus\

> \

> > > \

> > > > >

> > >

> HwrLTUd7h3NDk/fbm5X8xeY2kVW85e3m9vZ4Wn8M7V5UIYfwhpVgKDLs66B58JSics63Dt6v\

> \

> > > \

> > > > >

> > >

> bpeDEf4vekEX9H7YjhaXzZxYUNAgzL8UJeuIhB0VWxOlM7QNNXJI1NjCVkIFZyTUWZrM5rTJ\

> \

> > > \

> > > > >

> > >

> ljNW1WpAoJWwPrk0OL0pgxNh3tHs5NzXBy3h/Xp38l5SPtQt777G+1Jo43zQFVA0Mr4LbDr1\

> \

> > > \

> > > > >

> > >

> IoKY2eJs5NzClJjdWnmK3pfh5hPztcV9N2JZvyq+ad8uenH6Q8QtEosv3OYX9Z0nPj5EMLUr\

> \

> > > \

> > > > >

> > >

> HxF758PIR39eTBtsHFWDgStHtv6b5ZZb402xT0pTv1xd48AiEJW85ePu3uKL7u4Wd4YuIHCB\

> \

> > > \

> > > > >

> > >

> wTNwlf0/nZzG1p8NTyvqYMDaWoKVS+Go+VyafoBu4c89Hs+uyQvOxdfTpwe4d7R280tNs5MQ\

> \

> > > \

> > > > >

> > >

> NCM/OZKO74OQ1nrIzh4ah3TzReKgXwvV0gCSYNKZLzd3JKUf4PLvswHbJy5gaDZoQij0xGPf\

> \

> > > \

> > > > >

> > >

> 1bmTzkeOhSKyxpXYL6Xq9X8RUpZNsy2vIZR0UG/qFBoXwMQtA6oq4UfW6ftQe+LKlNTGOTj7\

> \

> > > \

> > > > >

> > >

> n4xHNXE16v5y2I4WseUT87pBrYH4YuMzxpJmdqAoPXh0O3wkqu30ZYx60mjTWFr2l8vhiM/c\

> \

> > > \

> > > > >

> > >

> kIo72IxHNEeeR1Q/jlT9eZ3UvLnGxyg5rhmIGitfC9XH3f3rudU5V/P8ZDrU+t4dng6OzwlZ\

> \

> > > \

> > > > >

> > >

> X/c3cuoiG2BbPmSSMcfd/frOPLJOYWS49Fk7z9KmXn5cXdv1cdUByBoA1C6tAxQGl+B7Cs8H\

> \

> > > \

> > > > >

> > >

> rbeGuHeEVn79eqaxE3bbdI33ZpRKPG4fOnvU9SYwhRvN7frRIuT8+wXb/ypavrsggPqqebBr\

> \

> > > \

> > > > >

> > >

> x8XgaCNse7p6fv+K68IGm25G5XhAtqrUpyExuvVtRxk8zyDtEv/ifxTFC+mr0n5L1LsuCZfn\

> \

> > > \

> > > > >

> > >

> Ds+kZ9wM2IaBoGgDbPuVARNJzriJ1dk292lx0ZoAo89+ckj3GwHELR56ArD7OScZGR8cWLUd\

> \

> > > \

> > > > >

> > >

> tBPh9nJOWocWgIEbRH1OT/EsG3ETwJNrwPwCwRtF+s0Dxd6gGL4MdbtK0/OkaRhIRC0jaxbN\

> \

> > > \

> > > > >

> > >

> Xt0/xDDziF3zUjSsBMI2l6kpuuW2oXBPWSsGWq2HAjaduJHiNhQY1Qc60ueOAZ0BAjaGRbD0\

> \

> > > \

> > > > >

> > >

> fPZpVxjxpc6hlvjMdgP946ezy7R8cQhIGjHoOstcr1hYOwcNFVw5cRFIGgnWfevQ3gaI2XIi\

> \

> > > \

> > > > >

> > >

> UF1QVF8zlEgaIeR4ekw1qIbo+Yj3qwdgWbXgaB9gOIelJaH0EdtR7yNJKIZfgBB+wO1IkVlj\

> \

> > > \

> > > > >

> > >

> xoOutb0fHaJ9r6eAUH7huyD51MHPIyNEe86RlFm6g9pevYBxUDQ3vIVvVNm3lPrWNaEM24Wj\

> \

> > > \

> > > > >

> > >

> IpDVkOlbpCIMvsNBO0/dCORTO19WyaPh6yRTaEM3ACsAxB0jaDuTc9nl+tLidhQuzComFG4d\

> \

> > > \

> > > > >

> > >

> 0RexulfrYCgawcFqcnUYewns3ETYcSHLA4uvYxQRg2BoOsL9eWTcWocKho28r8Ndl+vrhfDE\

> \

> > > \

> > > > >

> > >

> fVjND1TgDEgaCDEz52X16tr6tRHP6uxs9bjZZm/PDs5Jy9DyoCAoMEmMgAiS+jhXFGxlBvt9\

> \

> > > \

> > > > >

> > >

> Vdgo033SpC/DBKBoEEqX9E7yZquKf42WoWsy3n55wFKKX8+hEjGABlA0CAXX9E73VQkWW9LB\

> \

> > > \

> > > > >

> > >

> 9b+x8WxZuT0/9mQMoIYIA8QNCjDav4iY9azw1O6C0PBkHom8EkdU+DiqXUcjykjfAHKAUGDq\

> \

> > > \

> > > > >

> > >

> iyXSxkJoci1vBGzPmn00ddSx/EjvuezS7lNxh4ZVAeCBoqhYMhiOPq4u3+7uX0+u6S61VLWL\

> \

> > > \

> > > > >

> > >

> oZE4iEL2dDv+ezy7eb24+6e9siIJgPlQNCAF8q2Xs1fyNpvN7frjXYskL2xLd1QodqmBPE/u\

> \

> > > \

> > > > >

> > >

> KndlH9udngqt8bkYtIx9siAGwgamOF7ufperlbzFwqPUIREBkkotE3RbTk2xCrDCzvHhnnlH\

> \

> > > \

> > > > >

> > >

> 6R/Yj1OzilkLEX8+RCu5i/0Ok0/LVBTIGhgKV/RO+X50aCYiRy0E8854v8hBYhp0EYYoQlgL\

> \

> > > \

> > > > >

> > >

> RA0AABYCgQNAACWAkEDAIClQNAAAGApEDQAAFgKBA0AAJYCQQMAgKX8P0HSsuTfzO1nAAAAA\

> \

> > > \

> > > > > ElFTkSuQmCC]

> > > > >

> > > > > Weitz & Luxenberg p.c. Settlement Letter to Seroquel Victims -

> TIME

> > > TO

> > > > > REJECT this Insult on Top of Injury

> > > > > I would like to thank a brave, courageous, and ethical anonymous

> > > source

> > > > > who has send in this letter correspondence they received from

> the

> > > law

> > > > > firm of Weitz & Luxenberg. This letter doesn't require a whole

> lot

> > > of

> > > > > commentary.

> > > > > It's obvious that Law Firms have sold their clients down the

> > > proverbial

> > > > > river while at the same time enriching themselves (who's best

> > > interest

> > > > > are you obligated too fulfill?). This settlement offer and the

> > > injured

> > > > > litigants legal representation has carried out a blatant

> miscarriage

> > > of

> > > > > justice, a forever horrible stain upon the American Justice

> system,

> > > and

> > > > > a orchestrated crime perpetrated upon victims of this well

> > > documented &

> > > > > evidenced unbridled & unregulated corporate criminal enterprise

> gone

> > > a

> > > > > rye.

> > > > > The time has now come for the victims to stand up to this

> criminal

> > > > > corporation " AstraZeneca " & their poison drug " Seroquel " , to

> reject

> > > this

> > > > > horrible injustice and settlement offer. We want, what America &

> our

> > > > > Constitution promises us all, our day in court before a jury of

> our

> > > > > peers....

> > > > > ____________________________________________________________

> > > > >

> > > > > Weitz & Luxenberg P.C. <http://www.weitzlux.com/>

> > > > > We are happy to report excellent news! After a long and hard

> fought

> > > > > legal battle, AstraZeneca has agreed to participate in a

> Settlement

> > > > > Program to resolve Weitz & Luxenberg ( " W & L " ) Seroguel cases.

> Our

> > > > > patience and aggressive litigating has resulted in very

> favorable

> > > > > settlement terms for our clients which will be further outlined

> > > below.

> > > > > We have carefully reviewed all of the factors of this agreement

> and

> > > we

> > > > > believe that this settlement offers you the best, and very

> likely

> > > the

> > > > > only opportunity to receive a fair resolution of your lawsuit.

> > > > > Therefore, we strongly recommend that you sign and complete the

> > > enclosed

> > > > > " Release Form " , " Track Selection Form " and " Brief Questionnaire "

> and

> > > > > AGREE to participate.

> > > > > As you know, we have engaged in a long legal battle with

> AstraZeneca

> > > > > over the past 6 years. Weitz & Luxenberg led the charge for the

> > > > > Plaintiffs around the Country. AstraZeneca put up a tremendous

> and

> > > > > expensive defense and they successfully were able to get a large

> > > number

> > > > > of cases to be permanently dismissed by the court. Weitz &

> Luxenberg

> > > is

> > > > > the only firm who took a case to trial anywhere in the Country.

> > > However,

> > > > > after a month-long trial, the jury unfortunately ruled in favor

> of

> > > the

> > > > > defendants. This loss did not affect the strength of our fight.

> Over

> > > the

> > > > > past year, even as almost every other plaintiffs firm settled

> their

> > > > > cases, Weitz & Luxenberg prepared two more cases for trial which

> was

> > > > > scheduled to begin this Summer. As a direct result of the

> endless

> > > and

> > > > > consistent pressure applied by the attorneys at Weitz &

> Luxenberg,

> > > we

> > > > > are happy to report that AstraZeneca has now agreed to

> participate

> > > in a

> > > > > favorable settlement program. Based on public reports regarding

> > > > > settlement programs reached with other plaintiff law firms we

> are

> > > > > confident that the settlement program outlined below has more

> > > favorable

> > > > > terms and for this reason we are recommending your

> participation.

> > > > > The defendants have argued that they refuse to pay anyone who

> cannot

> > > > > prove through medical records or via certification that they

> have

> > > used

> > > > > Seroquel. They also refuse to pay anyone whose case is not

> active in

> > > > > this litigation. We recently told you about the Order issued by

> the

> > > > > Court requiring you to confirm when you started taking Seroquel

> and

> > > when

> > > > > you stopped taking Seroquel. We cannot stress enough that you

> MUST

> > > read,

> > > > > complete and return this certification form to us immediately.

> The

> > > > > failure to return this form within the next 30 days will result

> in

> > > the

> > > > > permanent dismissal of your case. In order to protect your legal

> > > rights,

> > > > > to keep your case active and be permitted to participate in this

> > > > > Settlement Program you must take this Order very seriously and

> you

> > > must

> > > > > respond.

> > > > > Based on our experience in other litigations and having reviewed

> the

> > > > > media reports of the terms of other firms' Seroquel settlement

> > > programs,

> > > > > we know that the defendants are looking for a settlement program

> > > that

> > > > > includes all claimants (W & L Seroquel Plaintiffs) so that they

> will

> > > > > achieve complete closure of the entirYlitigation. Our goal in

> this

> > > > > negotiation was to obtain a settlement for the most amount of

> money

> > > > > using a fair method to pay our clients based upon the merits of

> > > their

> > > > > individual case. We also stressed our intentions that the case

> > > review

> > > > > and payment process be performed quickly yet fairly so that our

> > > clients

> > > > > can receive their settlements as soon as possible. A key part of

> > > this

> > > > > settlement program is that a claimant cannot be part of the

> > > settlement

> > > > > if their case is dismissed and unless they provide, at the very

> > > least, a

> > > > > certification that they in fact took Seroquel and suffered an

> > > injury.

> > > > > Therefore, please make sure that you return your certification

> form

> > > to

> > > > > us immediately

> > > > >

> > > > > We have hired Hon.Marina Corodemus to act as the Special Master

> for

> > > the

> > > > > W & L Seroquel settlement program. Judge Corodemus previously ran

> the

> > > New

> > > > > Jersey Mass Tort Court and has a lot of experience in this

> field.

> > > She

> > > > > was appointed as a Special Master by the Vioxx State and Federal

> > > Court

> > > > > Judges to determine the appropriateness of Vioxx settlements and

> to

> > > > > resolve Vioxx appeals. She has also served as the Special Master

> in

> > > many

> > > > > other litigations such as Bextra and Celebrex which used similar

> > > > > settlement terms. We have met several times with Judge Corodemus

> and

> > > > > discussed the goals outlined above to get the most amount of

> money

> > > to

> > > > > the most amount of claimants in the fastest amount of time

> possible.

> > > We

> > > > > believe that Judge Corodemus is the perfect choice to create and

> > > oversee

> > > > > a settlement program in accordance with these goals. The W & L

> > > Seroquel

> > > > > Settlement Program involves Weitz & Luxenberg's 2,351 clients.

> Only

> > > > > those clients with active cases (not dismissed as outlined

> above)

> > > can

> > > > > participate in this settlement program. Unlike other settlement

> > > programs

> > > > > that you may have read about in the media and internet, the W & L

> > > > > Settlement program does not award every case an equal settlement

> > > amount.

> > > > > The size of an individual's settlement will depend entirely on

> the

> > > merit

> > > > > of that individual's case. As a direct result of the large

> number of

> > > > > cases represented by W & L, and the merits of those cases, we are

> > > > > confident that we have obtained the best possible settlement for

> our

> > > > > clients. After complex negotiations, AstraZeneca

> > > > > has agreed to deposit $92.25 Million dollars into a trust

> account to

> > > be

> > > > > used for this Settlement Program. This amount is completely

> > > confidential

> > > > > and you should NOT discuss this with anyone. A settlement of

> this

> > > type

> > > > > is called an " Aggregate Settlement " where a fair and reasonable

> sum

> > > of

> > > > > money is obtained to resolve multiple cases. In order to

> maintain

> > > proper

> > > > > representation of each individual client, W & L is NOT involved

> in

> > > the

> > > > > allocation decision making, which will be handled exclusively by

> > > Judge

> > > > > Corodemus. W & L has reviewed the general framework of the

> settlement

> > > > > plan with Judge Corodemus and we strongly believe that it is

> fair

> > > and

> > > > > reasonable and offers each of our clients the best possible

> outcome

> > > > > under the circumstances of this litigation. Track I offers the

> > > Seroquel

> > > > > claimant a settlement of $12,000. This track involves a simple

> > > review of

> > > > > each case and will result in a quick approval by Judge Corodemus

> > > without

> > > > > an analysis of the specific details of the case such as injury,

> > > amount

> > > > > of Seroquel taken, how close the last Seroquel use was to the

> date

> > > of

> > > > > the injury or the individual claimant's risk factors. a) Cannot

> > > > > prove that they suffered diabetes or a diabetes related

> condition,

> > > > > and/or Cannot prove that they used Seroquel within 1 year of

> > > > > their claimed injury, and/or c) Had a large number of known

> > > > > risk factors for diabetes before they started taking Seroquel.

> For

> > > > > example - obesity, family history, smoking, etc.

> > > > >

> > > > > Therefore, all cases whose injuries are limited to weight gain

> or

> > > high

> > > > > blood sugar and whose medical records will confirm that they

> were

> > > never

> > > > > diagnosed with diabetes or pancreatitis, should choose Track 1.

> > > > > Similarly, any claimed injury that occurred long after the last

> use

> > > of

> > > > > Seroquel should also choose Track 1. These cases are likely to

> > > receive a

> > > > > small award in Track II (likely less than $12,000) because it is

> > > > > extremely difficult to prove that these injuries were caused by

> > > > > Seroquel. Therefore, we suggest that if your case falls into

> this

> > > > > category you should choose Track 1. Additionally, payment of

> Track I

> > > > > settlement awards will be processed first once AstaZeneca waives

> its

> > > > > " walk away right " . (See Section IV© below) Track II involves

> an

> > > > > in-depth review of the severity of the injury, the claimed use

> of

> > > > > Seroquel and its proximity to the injury as well the available

> proof

> > > > > found in the contemporaneous medical records. Additionally,

> Judge

> > > > > Corodemus will strongly consider many known risk factors for

> these

> > > > > injuries including but not limited to smoking, obesity and

> family

> > > > > history as well as the participation in the Zyprexa settlement

> for

> > > these

> > > > > same injuries. This model is very similar to the one used in the

> > > > > National Vioxx Settlement Program as well as dozens of other

> similar

> > > > > settlement programs which were successfully resolved in recent

> > > years.

> > > > > Judge Corodemus has established a points system and will

> consider

> > > all of

> > > > > the critical issues including but not limited to:

> > > > > - Nature of the injury - Severity of the injury - Age at the

> time of

> > > > > injury - Proximity of Seroquel use to the claimed injury -

> Changes

> > > in

> > > > > the Seroque11abel - Risk Factors including Smoking, Body Mass

> Index,

> > > > > etc. After carefully reviewing all of the medical records and

> the

> > > > > individual fact sheet, Judge Corodemus will assign a point value

> to

> > > each

> > > > > case. The more points a case is awarded based on the specific

> facts

> > > of

> > > > > the case, the larger the settlement will be. At this time, there

> is

> > > no

> > > > > way to predict with accuracy how many points an individual case

> may

> > > be

> > > > > awarded and it is even more difficult to determine how much

> money

> > > each

> > > > > point will receive. The exact value of each point will depend on

> the

> > > > > number of participants in Track II and the total number of

> points

> > > > > assigned. All cases in Track II will be eligible for a

> settlement

> > > award

> > > > > but Judge Corodemus could award LESS than $12,000 (what people

> will

> > > > > receive automatically by choosing Track 1) if the case lacks

> merit.

> > > In

> > > > > the interest of fairness, Judge Corodemus has committed to

> review

> > > each

> > > > > case in Track II very carefully and this process will take time

> to

> > > > > complete. Judge Corodemus has stated that she hopes to have this

> > > process

> > > > > completed by the end of 2011 but please be warned that it could

> take

> > > a

> > > > > little longer due to the amount of work that is involved.

> However,

> > > in

> > > > > order to get this settlement process moving forward and

> ultimately

> > > paid

> > > > > you must send us your signed Release form as soon as possible.

> If

> > > you

> > > > > choose Track I your settlement award of $12,000 is set. If you

> > > choose

> > > > > Track II, Judge Corodemus will review your claim and will issue

> an

> > > > > award. We expect that we will contact you in approximately

> November

> > > 2011

> > > > > and notify you of your point award and the expected amount of

> your

> > > > > settlement. At that point, you will be given a choice to accept

> your

> > > > > award, appeal your award or withdraw from the settlement

> program. If

> > > you

> > > > > accept, we will forward your release to AstraZeneca for their

> review

> > > and

> > > > > approval. Please understand that this settlement is not official

> > > until

> > > > > we send AstraZeneca your signed Release Form, AstraZeneca

> approves

> > > it

> > > > > AND AstraZeneca waives its walk away right. In the interest of

> time,

> > > we

> > > > > are asking you to return your signed Release Form now so we can

> meet

> > > the

> > > > > tight deadlines associated with this settlement. If you are

> unhappy

> > > with

> > > > > your allocation amount and/or believe that your case involves

> > > > > " Extraordinary Injury or Circumstances " you have the right to

> appeal

> > > > > your award. Upon receipt of such an application, Judge Corodemus

> > > will

> > > > > re-review your records and make a final decision. Please be

> aware

> > > that

> > > > > there is no additional right of appeal (to Judge Corodemus or to

> any

> > > > > Court) once this final decision is made. If you decide to

> decline

> > > the

> > > > > settlement amount offered to you, you must notify us within ten

> days

> > > of

> > > > > your receipt of your allocation amount and your signed Release

> Form

> > > will

> > > > > no longer be valid. As in all settlements of this type, our

> > > agreement

> > > > > with the defendant depends on nearly full participation from all

> of

> > > our

> > > > > clients. Under the terms of our agreement, we must provide

> > > Qualifying

> > > > > Materials (Release Form and/or Dismissal) for 2,260 of our

> clients.

> > > Once

> > > > > we reach this number, AstraZeneca's " walk away right " is

> officially

> > > > > waived. We strongly believe that our clients will agree that

> this

> > > > > settlement program offers the best possible terms and we expect

> that

> > > we

> > > > > will meet this requirement in the next 90-120 days. In order to

> meet

> > > > > this deadline we MUST have your complete

> > > > > cooperation and immediate response. Of course, if we do not meet

> > > this

> > > > > required number of responses, Astrazeneca can decide to withdraw

> its

> > > > > settlement offer to everyone whether one signed the Release Form

> or

> > > not.

> > > > > Therefore, time is of the essence. A. Release Form: Enclosed you

> > > will

> > > > > find a Release Form which you must sign in front of a notary in

> > > Order to

> > > > > participate in the settlement. If you have a spouse he/she must

> sign

> > > the

> > > > > Release Form as well. Attached to the Release Form will be an

> > > > > instruction sheet to guide you to ensure that this important

> form is

> > > > > signed the right way. A Release Form that is signed the wrong

> way or

> > > > > that is not witnessed (by a notary) is useless and will not be

> > > accepted

> > > > > by the defendants. The Release Form is your agreement to

> participate

> > > in

> > > > > the settlement program and at the same time discontinue your

> lawsuit

> > > in

> > > > > exchange for your settlement award. Please turn to Page 2 of the

> > > Release

> > > > > Form and complete the details of your Seroquel use. You may

> refer to

> > > > > Page 1 of the Brief Questionnaire which lists the Seroquel

> > > information

> > > > > that was found in your medical records or that you have

> previously

> > > > > provided to us. If this information is inaccurate, please cross

> it

> > > out

> > > > > and write in when you started and when you stopped taking

> Seroquel

> > > on

> > > > > BOTH the Release Form and the Brief Questionnaire. Due to the

> fast

> > > > > approaching deadlines, and our goal to get you your settlement

> > > processed

> > > > > and paid as quickly as possible, we MUST receive this signed

> release

> > > > > form back from you before August 31, 2011. Please use the

> envelope

> > > > > provided herein and return the signed and notarized release form

> > > today

> > > > > before you forget about it. Please note that once we submit your

> > > release

> > > > > form to AstraZeneca it can not be revoked. B. Track Selection

> Form:

> > > > > Enclosed you will find a " Track Selection Form " which is the

> form

> > > used

> > > > > to officially notify the Special Master which Track you want

> your

> > > case

> > > > > to follow. Please Note that there are 4 options on this form.

> You

> > > MUST

> > > > > check one of the Options. If you want to participate in this

> > > settlement,

> > > > > and we strongly think that you should, you must check either

> Track I

> > > OR

> > > > > Track II and you must sign the bottom of the form. Your Track

> > > selection

> > > > > cannot be changed and is considered final once the Judge's

> > > Allocations

> > > > > are made. In other words, a person who chooses Track II and is

> > > awarded

> > > > > less than $12,000 CANNOT then choose to go to Track 1 for a

> higher

> > > > > award. C. Brief Questionnaire: Enclosed you will find a 3

> > > > > page Brief Questionnaire which has important information about

> your

> > > > > claim. For all claimants who choose to enter Track II, Judge

> > > Corodemus

> > > > > will be reviewing your medical records, your Fact Sheet and this

> > > Brief

> > > > > Questionnaire and will issue a point award. Judge Corodemus will

> > > > > consider the proof of your claim found in your medical records

> as

> > > well

> > > > > as the information that you provide in this Questionnaire.

> > > Therefore, it

> > > > > is important that you answer these questions honestly and

> completely

> > > and

> > > > > that they are consistent with what is found in your medical

> records.

> > > > > litigation and our conversations with our medical experts, it is

> > > clear

> > > > > that Seroquel lawsuits are very difficult to win, very

> expensive,

> > > and

> > > > > very time consuming to take through to trial, verdict and

> appeal.

> > > Over

> > > > > the past six years only I case (from W & L) of24,000 cases in the

> > > Country

> > > > > made it to and through trial. Countless other cases were

> prepared

> > > and

> > > > > then dismissed based on merit and/or inability to prove that

> > > Seroquel

> > > > > caused the injury. Just because an individual took Seroquel and

> > > suffered

> > > > > an injury like diabetes does not mean that such a case will win

> at

> > > > > trial. In order to succeed at trial, a plaintiff must prove both

> > > that

> > > > > Seroquel can cause such an injury in general AND that, within a

> > > > > reasonable degree of medical certainty, Seroquel caused this

> injury

> > > to

> > > > > this particular person (despite any individual risk factors such

> as

> > > > > smoking, weight, high blood sugar, family history etc.). We have

> > > told

> > > > > you in the past update letters that the Courts have consistently

> > > ruled

> > > > > in favor of the defendants on many of these issues and have

> > > prohibited

> > > > > medical experts from testifying because of a lack of scientific

> > > proof

> > > > > linking the plaintiff s injuries to his/her Seroquel use. It is

> also

> > > > > important to note that even if your case is able to advance past

> > > this

> > > > > judicial scrutiny, a trial of this magnitude will cost over

> $750,000

> > > per

> > > > > case and many of these costs are reimbursed off of the top of a

> > > > > favorable verdict reducing the amount received by the plaintiff.

> > > > > Furthermore, any case that is won at trial will surely face a

> > > lengthy

> > > > > and hard-fought appeal. Finally, nearly all of the Seroquel

> cases

> > > are

> > > > > being handled by three judges. Even at an accelerated pace, the

> > > chances

> > > > > are slim that your case would be tried in the next 10 years if

> not

> > > > > longer. In taking all of these factors into consideration, and

> > > > > considering the issues of risk and reward, we believe that a

> > > settlement

> > > > > of this type offers you the most advantageous resolution

> possible.

> > > You

> > > > > will be notified once the Special Master issues your point award

> at

> > > > > which point you can appeal to the Special Master if you believe

> that

> > > > > your case involves extraordinary circumstances. Thereafter, the

> > > decision

> > > > > of the Special Master is final, binding and non-appealable. We

> have

> > > > > retained the Garretson Law Firm to negotiate any and all Federal

> and

> > > > > State liens (Medicare/Medicaid/SSI) that may be applicable in

> your

> > > case.

> > > > > The Garretson Firm is a specialist in this field and they have

> > > obtained

> > > > > excellent results in their negotiation of similar liens in other

> > > > > litigations like Vioxx, Bextra, and Celebrex. Moreover, the

> > > Garretson

> > > > > Firm has already worked on thousands of other Seroquel cases and

> has

> > > > > been able to achieve excellent results in large part due to the

> > > volume

> > > > > of cases that they are able to include in a Global Resolution.

> At

> > > this

> > > > > time, the Garretson Firm has already negotiated with 44

> individual

> > > > > states regarding Medicaid and they have reached an agreement to

> CAP

> > > > > Medicaid liens at a maximum of 20% of the settlement amount.

> Please

> > > see

> > > > > the enclosed blue booklet regarding governmental liens for more

> > > details.

> > > > > Additionally, please also be advised that if you or Weitz &

> > > Luxenberg

> > > > > are put on written notice of a private lien, for example from

> your

> > > > > medical provider, this lien must be resolved before any

> settlement

> > > > > proceeds can be distributed. If you have received any notice of

> a

> > > lien,

> > > > > please advise us immediately. The terms of your signed

> contingency

> > > fee

> > > > > agreement will be in effect. We have taken great effort to keep

> the

> > > case

> > > > > specific expenses as low as possible. Under the terms of your

> > > agreement,

> > > > > the

> > > > > contingency fee will be calculated after the expenses are

> deducted.

> > > > > Under the terms of our agreement with AstraZeneca, any interest

> > > earned

> > > > > on the settlement proceeds before allocation and payment to the

> > > > > individual clients will be used to offset the fixed costs of the

> > > Special

> > > > > Master and the Lien Administrator. Due to the low interest rates

> > > paid by

> > > > > all banks in this economy, we do not expect that there will be

> any

> > > > > leftover interest. However, in such a case, the leftover

> interest

> > > will

> > > > > be added to the settlement trust and will be distributed to all

> > > > > claimants as part of Judge Corodemus' allocation process. After

> > > careful

> > > > > analysis of the likelihood of success in the court system, as

> well

> > > as

> > > > > the cost and time elements involved, we strongly recommend that

> you

> > > > > AGREE to participate in this settlement. We are confident that

> this

> > > > > settlement is the best possible resolution of your claim

> especially

> > > in

> > > > > light of the history of this litigation. We expect that any case

> > > that

> > > > > does not agree to participate in this settlement will have a

> very

> > > > > difficult time navigating through the Court system and trial

> dates

> > > may

> > > > > not be set for many years. Moreover, as we have seen, these

> cases

> > > will

> > > > > be aggressively defended by AstraZeneca and we expect that we

> will

> > > > > receive motions to dismiss and unfavorable decisions from the

> Court

> > > on

> > > > > unsettled cases in the coming months. Moreover, if this

> settlement

> > > > > program is not successful (we fail to reach the 98% response

> rate)

> > > we

> > > > > highly doubt that we will ever obtain a settlement amount and

> terms

> > > as

> > > > > good as those contained in this program. While we hope that this

> > > letter

> > > > > and enclosures will help answer all of your questions, we

> understand

> > > > > that you may have additional questions for us. Please keep in

> mind

> > > that

> > > > > we are working very hard to evaluate each and every case

> > > individually

> > > > > and the many deadlines that are part of this settlement are fast

> > > > > approaching. Your case has been assigned to Judy Koenig. If you

> have

> > > an

> > > > > important question please call Judy Koenig at (800) 438-9786 and

> ask

> > > for

> > > > > extension 5860. If you reach a voice-mail, please leave a

> message

> > > and

> > > > > you will be called back as quickly as possible. Please do not

> leave

> > > > > multiple voicemail messages on the same day as that will slow

> down

> > > our

> > > > > ability to return your call. Additionally, if you have email

> access,

> > > > > please try to email your detailed questions to us at sqinfo@

> > > > > <mailto:sqinfo@ and we will get back to you quickly. If

> > > > > this letter has successfully answered your questions, and you

> have

> > > > > decided to participate, please carefully follow the directions

> on

> > > the

> > > > > front page of the enclosed release form and send your signed and

> > > > > witnessed release formes), your Track Selection AND your Brief

> > > > > Questionnaire to us as soon as possible. If you still have

> questions

> > > > > after reviewing this letter and after speaking to us over the

> > > telephone

> > > > > and you would like to meet us in person, we will be happy to

> > > schedule a

> > > > > meeting in our office at your convenience. Finally, please

> remember

> > > that

> > > > > the detailed information regarding this settlement program is

> > > COMPLETELY

> > > > > CONFIDENTIAL and should not be shared or discussed with anyone.

> > >

> > > > > Sedgh, Esq Glenn Zuckerman, Esq.

> > > > >

> > > >

> > >

> >

>

August 27, 2011